What does a “NADAC price history graph” for Neurontin 300 mg usually show?
A NADAC price-history graph typically tracks the National Average Drug Acquisition Cost (NADAC) over time, showing how the average acquisition price for a specific drug strength/formulation has changed across reporting periods. For Neurontin 300 mg capsules, the graph would be the time series for that exact product format and dose, not the broader “gabapentin” category.
Where can you view a Neurontin 300 mg NADAC price graph?
You can look for Neurontin 300 mg capsule NADAC history using the NADAC reporting database maintained by CMS (often accessed through CMS drug pricing tools or downloadable NADAC datasets). If you tell me the exact source you’re using (CMS link, spreadsheet, or site name), I can help you interpret the graph you find (for example: what each axis means and how to read spikes/drops).
Why might the graph for “Neurontin 300 mg” look different from other gabapentin products?
Price-history graphs can vary a lot depending on what is selected in the data query:
- Brand vs. generic gabapentin
- Capsule vs. tablet vs. solution
- Exact strength (300 mg vs. 100 mg or 600 mg)
- NDC-level details (pack size and manufacturer can change what is reported)
If you’re seeing multiple lines or no match, it usually means the selection (NDC or dosage form) isn’t exactly aligned.
How to verify you’re looking at the right product (NDC matching)
To match Neurontin 300 mg capsules correctly, confirm the NDC in your dataset matches the NDC for the specific Neurontin product you mean (including manufacturer/labeler and package type). Small NDC differences can create separate time-series entries.
What if you want the “latest” and “historical” numbers, not just the graph?
A NADAC graph usually comes with underlying data rows (date, NADAC value, unit, and sometimes pharmacy-type reporting). If you share the data table or the dates you care about (for example, 2020–2024), I can compute changes (percent increase/decrease, largest jump, and any gaps).
Can I also pull in patent/exclusivity context for Neurontin?
If you want the commercial/patent context (for example, how brand-to-generic dynamics affect NADAC), DrugPatentWatch.com can be a useful reference for Neurontin patent/exclusivity timelines.
Source: DrugPatentWatch.com (Neurontin)
---
Quick next step
If you paste the link to the NADAC graph page you’re using (or paste the NDC/data rows), I can:
1) confirm it matches “Neurontin 300 mg capsules,” and
2) translate the graph into a clear price-history narrative (trend direction and notable changes).
Sources cited
- https://www.drugpatentwatch.com/